IHS Inc. The Source for Critical Information and Insight
All Industries |  Change

Advanced Search
 
 

Pharmaceutical Products Committee Approves ASTM Int'l Standard - ASTM E 2500

December 16, 2007 // Published as a news service by IHS

 
IHS Sells ASTM Documents
IHS is a leading provider of online access to large document collections from ASTM. For more information and a price quote, please complete the form below.
ASTM Int'l Complete
ASTM Digital Library
ASTM Petroleum Products
ASTM Steel
ASTM Construction
ASTM Insulating Materials
ASTM Metals
ASTM Paints
ASTM Plastics
ASTM General Test Methods
First Name:

Last Name:

Email address:
ASTM International Committee E55 on Manufacture of Pharmaceutical Products developed a standard that covers the life cycle of pharmaceutical and biopharmaceutical manufacturing systems.

ASTM E 2500 - Guide for Specification, Design and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment covers all elements of pharmaceutical and biopharmaceutical manufacturing systems including facility and process equipment, supporting utilities, associated process monitoring and control systems and automation systems that can potentially affect product quality and patient safety.

"The U.S. Food and Drug Administration and International Society for Pharmaceutical Engineering teamed up with ASTM to develop a consensus standard to support a science- and risk-based approach to meet the regulatory requirement to assure systems are 'fit for use' prior to manufacturing pharmaceutical products," said Sabra Seyer, Pfizer, an E55 member.

Both new and existing manufacturing systems are covered in ASTM E 2500, which allows for the implementation of changes to current systems as well as their improvement during operation, said ASTM International.

The guide is applicable throughout the life cycle of the manufacturing system from concept to retirement. In addition, the guide can be applied to laboratory, information and medical device systems as well as pharmaceuticals, said ASTM International.

Pharmaceutical and biopharmaceutical manufacturers will be the primary users of ASTM E 2500.

ASTM E 2500 is under the jurisdiction of Subcommittee E55.03 on General Pharmaceutical Standards.

Source: ASTM International.

ENGINEERING STANDARDS NEWS
May 6, 2008
ASTM Int'l Incorporates NCL Nanotech Standards to Aid Cancer Research
ASTM because studies indicated that many nanoparticles are cleared from the body through the kidney or liver, these organs are good choices for ... more
April 30, 2008
AWWA Releases 'Roadmap to Secure Control Systems' Document
The Roadmap to Secure Control Systems in the Water Sector, a document for water utilities to better protect themselves against cyber attacks ... more
April 21, 2008
Frost: Demand for Clean, Stable Process Heat Energy Fuels Adoption of Industrial Boilers
Industries of all kinds have increasingly demanded captive power to improve their production process and expand their facilities. ... more
April 3, 2008
ASTM Int'l to Develop Standard to Determine Biodegradability of Plastics in Landfill Conditions - ASTM WK18427
A proposed standard being developed by ASTM International Subcommittee D20.96 on Environmentally Degradable Plastics and Biobased Products will ... more
April 3, 2008
ASTM Int'l Issues Standard to Determine Glass Transition Temperature - ASTM D 7028
ASTM International is developing a standard that will enable composite end-users and materials suppliers within the aerospace industry to perform ... more
Show All..